The Market LogEnter at least 2 characters. Company and ticker searches are not case-sensitive.

Company profile

Lipocine Inc. insider acquisitions

Company CIK 0001535955 · Reported insider acquisitions and filing context.

Company filings at SEC ↗
LPCN · Nasdaq

These are company listings. A transaction is linked to a particular security only when the filing provides enough information.

Company activity summary

By transaction date, as of October 23, 2026.

7 days30 days90 daysOverlapping periods · securities and currencies kept separate

No records are loaded for this 7-day transaction window. This does not establish that no transactions occurred.

Known purchase value sums available amounts for non-derivative purchases only. Missing amounts are excluded. “Currency not specified” does not establish that the amounts share a currency. These summaries use all matching loaded records, while the timeline below covers only the current page.

Transaction timeline

Who reported an acquisition, and when the transaction occurred.

Reported acquisitions by transaction dateEach row is a reporting owner. Select a marker to open its transaction details. Jointly reported transactions appear for each associated reporting owner, without dividing quantities or amounts.Higuchi John W.Higuchi John W.Patel Mahesh V.Patel Mahesh V.Fogarty KristaFogarty KristaHiguchi John W. · September 30, 2026 · Purchase · Common stockHiguchi John W. · September 29, 2026 · Purchase · Common stockPatel Mahesh V. · December 18, 2025 · Stock award · Stock Option (Right to Buy)Fogarty Krista · December 18, 2025 · Stock award · Stock Option (Right to Buy)Dec 18, 2025Sep 30, 2026
PurchaseStock awardGift receivedExercise / conversionConversionOther acquisition

4 dated transactions · 3 of 3 reporting owners shown. Select one owner to focus the chart.

View timeline as a table
Transaction dateCompany / securityReporting ownersAcquisition type
Sep 30, 2026Lipocine Inc.Common stockHiguchi John W.Purchase
Sep 29, 2026Lipocine Inc.Common stockHiguchi John W.Purchase
Dec 18, 2025Lipocine Inc.Stock Option (Right to Buy)Patel Mahesh V.Stock award
Dec 18, 2025Lipocine Inc.Stock Option (Right to Buy)Fogarty KristaStock award

Only transactions on this page are shown. Date windows end on the latest transaction date in this sample. Joint filings may appear on more than one row. Sales are not included. Share-price charts use a separate data source.

Share price & reported acquisitions

Daily closing prices from a separate source. The date window above also filters prices; reporting-owner and transaction-type selections filter the markers.

Price history is not available

Market-price history is not connected yet.

LPCN · Currency not specified. A marker uses that day's closing price, not the reported transaction price. No price is substituted for a missing trading day.

Reported acquisitions

Filing-date filters apply to the list and timeline. The summary above uses transaction dates.

Reset
Reported insider acquisitions, ordered by filing date, newest first. Currency is shown only when reported.
Filed / transactedReporting ownersType / securityQuantityPrice / reference valueDetails
Trade: PurchaseCommon stockNon-derivative security · Code P15,9702.23Value: 35,613.1Currency not specifiedView ↗
Trade: PurchaseCommon stockNon-derivative security · Code P9,0372.15Value: 19,429.55Currency not specifiedView ↗
Trade:
Patel Mahesh V.Chief Executive Officer · Director
Stock awardStock Option (Right to Buy)Derivative security · Code A8,6294.2Value: 36,241.8Currency not specifiedView ↗
Trade:
Fogarty KristaPrincipal Accounting Officer
Stock awardStock Option (Right to Buy)Derivative security · Code A20,7864.2Value: 87,301.2Currency not specifiedView ↗

Reporting owners are associated with a filing. Jointly reported amounts are not allocated to individual owners. Historical coverage is still being built. Read the methodology →